Kevin S Shah, Nicholas A Marston, Christian Mueller, Sean-Xavier Neath, Robert H Christenson, James McCord, Richard M Nowak, Gary M Vilke, Lori B Daniels, Judd E Hollander, Fred S Apple, Chad M Cannon, John Nagurney, Donald Schreiber, Christopher deFilippi, Christopher J Hogan, Deborah B Diercks, Alexander Limkakeng, Inder S Anand, Alan H B Wu, Paul Clopton, Allan S Jaffe, W Frank Peacock, Alan S Maisel
OBJECTIVES: Chest pain is a common complaint to emergency departments (EDs) and clinical risk factors are used to predict which patients are at risk for worse outcomes and mortality. The goal was to assess the novel biomarker midregional proadrenomedullin (MR-proADM) in prediction of mortality and major adverse cardiac events (MACE). METHODS: This was a subanalysis of the CHOPIN study, a 16-center prospective trial that enrolled 2,071 patients presenting with chest pain within 6 hours of onset...
May 2015: Academic Emergency Medicine